BRAF-mutant melanoma: treatment approaches, resistance mechanisms, and diagnostic strategies

BRAF inhibitors vemurafenib and dabrafenib achieved improved overall survival over chemotherapy and have been approved for the treatment of BRAF-mutated metastatic melanoma. More recently, the combination of BRAF inhibitor dabrafenib with MEK inhibitor trametinib has shown improved progression-free...

Descripción completa

Detalles Bibliográficos
Autores principales: Spagnolo, Francesco, Ghiorzo, Paola, Orgiano, Laura, Pastorino, Lorenza, Picasso, Virginia, Tornari, Elena, Ottaviano, Vincenzo, Queirolo, Paola
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2015
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4303458/
https://www.ncbi.nlm.nih.gov/pubmed/25653539
http://dx.doi.org/10.2147/OTT.S39096

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4303458/
https://www.ncbi.nlm.nih.gov/pubmed/25653539
http://dx.doi.org/10.2147/OTT.S39096

Ejemplares similares